ClinicalTrials.Veeva

Menu

A Combinatorial Biomarker for Infection Diagnosis in Children (CROCODILE-I)

U

Universität des Saarlandes

Status

Enrolling

Conditions

Fever
Respiratory Tract Infections

Treatments

Diagnostic Test: BV

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

To describe the epidemiology, clinical presentation, diagnosis, therapy, and treatment outcomes of patients in whom the combination biomarker BV (combination of TRAIL, IP-10, and CRP) is used, and to compare them with control patients without BV measurement.

Secondary objectives:

  • Qualitative evaluation of indication as well as adherence to the test result.
  • Comparison of antimicrobial therapy, performed diagnostics, hospitalization, and outcomes between patients with high BV score (bacterial) and patients with low BV score (viral).

Enrollment

770 estimated patients

Sex

All

Ages

5+ months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Suspicion of acute bacterial or viral infection
  • Requirement of at least one BV test during medical presentation

Exclusion criteria

  • lack of informed consent

Trial design

770 participants in 2 patient groups

BV use cases
Description:
cases in whom BV was ordered
Treatment:
Diagnostic Test: BV
BV non-use cases
Description:
cases in whom BV was not ordered

Trial contacts and locations

4

Loading...

Central trial contact

Soeren Becker, MD, PhD; Cihan Papan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems